Mineralys Therapeutics Current Assets

As of the most recent data (March 2026), MLYS shows a current assets of $650M. That compares with $350M in the prior-year period — up 84.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MLYS's current assets is now $650M (was $350M) — a 84.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Mineralys Therapeutics is outperforming or lagging.

Tracking MLYS's current assets over time shows whether Mineralys Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $650M That compares with $350M in the prior-year period — up 84.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Mineralys Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $650M) with ownership activity and broader fundamentals.